INBS
INTELLIGENT BIO SOLUTIONS INC.Company Information
- Company Name
- INTELLIGENT BIO SOLUTIONS INC.
- CIK
- CIK0001725430
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- INBS: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- INBS
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-10-04
- Last sale
- 2022-02-17
- Shares purchased (TTM)
- 121,867
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 181,362
- Shares outstanding
- 1,472,744
- Ownership
- 12.31%
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- -20.22%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 7 | 1 | 2 | 1 | 3 | 2 | 4 | 6 | 9 | 1 | 0 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | ||||||
| Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock | - | - | 9 | - | - | - | - | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 7 | 10 | 12 | 4 | 4 | 5 | 4 | 6 | 9 | 12 | 3 | 3 | ||||||
| Inventory Net | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | - | - | 1 | - | - | - | - | - | - | - | ||||||
| Other Assets Current | 1 | - | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | ||||||
| Assets | 12 | 15 | 18 | 10 | 8 | 10 | 9 | 12 | 14 | 17 | 9 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 4 | 4 | 4 | 4 | 5 | 1 | 1 | 2 | 2 | 2 | 2 | 4 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 6 | 5 | 6 | 5 | 7 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Current | - | - | - | - | - | 2 | 2 | 3 | 2 | 2 | 2 | 2 | ||||||
| Employee Related Liabilities Current | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Notes Payable Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 2 | 1 | 2 | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities | 7 | 6 | 7 | 7 | 5 | 5 | 4 | 6 | 6 | 6 | 6 | 7 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 6 | 9 | 11 | 3 | 3 | 5 | 4 | 6 | 8 | 11 | 3 | 1 | ||||||
| Additional Paid In Capital | 81 | 80 | 80 | 69 | 66 | 65 | 62 | 61 | 61 | 61 | 50 | 46 | ||||||
| Retained Earnings Accumulated Deficit | -75 | -71 | -68 | -66 | -63 | -59 | -57 | -55 | -52 | -49 | -46 | -44 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -0 | -0 | -0 | -0 | -1 | -1 | -0 | -1 | -1 | -1 | -1 | ||||||
| Minority Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 12 | 15 | 18 | 10 | 8 | 10 | 9 | 12 | 14 | 17 | 9 | 9 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 100 | 100 | - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 3 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialINTELLIGENT BIO SOLUTIONS INC. (INBS) — SEC Financial Statements & Analysis
INTELLIGENT BIO SOLUTIONS INC. (INBS) is a surgical & medical instruments & apparatus company, incorporated in DE. INTELLIGENT BIO SOLUTIONS INC. trades on Nasdaq as: INBS. INTELLIGENT BIO SOLUTIONS INC. (INBS)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), INTELLIGENT BIO SOLUTIONS INC. carries a market cap of $3.38M, a P/E ratio of -0.27x, a P/B ratio of 0.64x, a P/S ratio of 0.80x, an enterprise value of $-612.36K, and an EV/EBITDA multiple of 0.05x. On profitability, it posts a gross margin of 48.63%, an operating margin of -299.11%, a net margin of -295.80%, a Return on Equity (ROE) of -307.69%, a Return on Assets (ROA) of -123.50%, and a Return on Invested Capital (ROIC) of -734.11%. Per share, it reports EPS of $-8.47, diluted EPS of $-8.47, free cash flow per share of $-8.20, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 38.09% year-over-year, net income growth of 17.98% year-over-year, and EPS growth of -57.75% year-over-year. On the balance sheet, it maintains a current ratio of 1.44x, a quick ratio of 1.15x, working capital of $2.17M, a debt-to-equity ratio of 1.26x, a debt ratio of 0.56, an interest coverage ratio of -106.88x, free cash flow of $-12.08M (TTM), and net debt of $-3.99M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.38M
- P/E TTM
- -0.27x
- EPS TTM
- $-8.47
- P/B TTM
- 0.64x
- ROE TTM
- -307.69%
- ROA TTM
- -123.50%
- Debt To Equity
- 1.26x
- Free Cash Flow TTM
- $-12.08M
- Net Revenue TTM Growth 1Y
- 38.09%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INTELLIGENT BIO SOLUTIONS INC. in?
INTELLIGENT BIO SOLUTIONS INC. (INBS) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does INBS trade on?
INTELLIGENT BIO SOLUTIONS INC. (INBS) trades on the Nasdaq.
Where is INTELLIGENT BIO SOLUTIONS INC. incorporated?
INTELLIGENT BIO SOLUTIONS INC. is incorporated in DE.
When was INTELLIGENT BIO SOLUTIONS INC. (INBS)'s most recent SEC filing?
INTELLIGENT BIO SOLUTIONS INC. (INBS)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is INBS's market cap?
INTELLIGENT BIO SOLUTIONS INC. (INBS) has a market capitalization of $3.38M as of 2026-06-30.
What is INBS's EPS (earnings per share)?
INTELLIGENT BIO SOLUTIONS INC. (INBS)'s trailing twelve month EPS is $-8.47 as of 2026-06-30.
What is INBS's ROE (return on equity)?
INTELLIGENT BIO SOLUTIONS INC. (INBS)'s trailing twelve month Return on Equity (ROE) is -307.69% as of 2026-06-30.
What is INBS's ROA (return on assets)?
INTELLIGENT BIO SOLUTIONS INC. (INBS)'s trailing twelve month Return on Assets (ROA) is -123.50% as of 2026-06-30.
What is INBS's ROIC (return on invested capital)?
INTELLIGENT BIO SOLUTIONS INC. (INBS)'s trailing twelve month Return on Invested Capital (ROIC) is -734.11% as of 2026-06-30.
What is INBS's EV/EBITDA?
INTELLIGENT BIO SOLUTIONS INC. (INBS)'s trailing twelve month EV/EBITDA is 0.05x as of 2026-06-30.